Andrew Dalton
EMEA Vice President, Johnson & Johnson MedTech, Orthopaedics
Andrew brings 30 years of healthcare industry experience, currently leading the Joint Reconstruction Business for Johnson & Johnson in the EMEA region. Over his 22-year tenure at J&J, he has held leadership roles across Orthopaedics in both the UK and EMEA, including five years managing the UK business. With a background in Clinical Diagnostics and Pharma, Andrew is known for driving commercial success and is passionate about developing future leaders.
1 blog from the author
Posted on 12.10.2024
From burden to breakthrough: Orthopaedic innovations for osteoarthritis care
On World Arthritis Day, we are reminded of over 40 million people in Europe, who live with osteoarthritis (OA), a condition affecting 15% of the global population over the age of 30. In France, for example, it is the second-leading reason for medical consultations, after cardiovascular conditions. As life expectancy increases, the burden of osteoarthritis […]
Medtech Views
Curated by
